iLIVER Open Access Editor-in-Chief: Jiahong Dong
Home iLIVER Most Cited
Most Cited:30most cited articles
Review | Open Access
Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma
Published: 09 February 2024
2024, 3(1)
Review | Open Access
Liver transplantation for malignant liver tumors
Published: 18 April 2022
2022, 1(1): 3-11
Review | Open Access
Advances in magnetic particle imaging and perspectives on liver imaging
Published: 08 November 2022
2022, 1(4): 237-244
Review | Open Access
Transarterial chemoembolization in combination with programmed death-1/programmed cell death-ligand 1 immunotherapy for hepatocellular carcinoma: A mini review
Published: 04 November 2022
2022, 1(4): 225-234
Original Article | Open Access
Free fatty acid-induced miR-22 inhibits gluconeogenesis via SIRT-1-mediated PGC-1α expression in nonalcoholic fatty liver disease
Published: 07 February 2023
2023, 2(1): 1-9
Review | Open Access
When liver disease diagnosis encounters deep learning: Analysis, challenges, and prospects
Published: 04 March 2023
2023, 2(1): 73-87
Original Article | Open Access
The transjugular intrahepatic portosystemic shunt: Smaller stent diameters are required to optimize pressure response
Published: 27 May 2023
2023, 2(2): 89-96
Review | Open Access
Perihilar cholangiocarcinoma: a surgeon's perspective
Published: 05 April 2022
2022, 1(1): 12-24
Original Article | Open Access
Exploratory study of microparticle transcatheter arterial chemoembolization combined with resection for huge hepatocellular carcinoma
Published: 07 March 2022
2022, 1(1): 35-42
Review | Open Access
Radiomics/Radiogenomics in hepatocellular carcinoma: Applications and challenges in interventional management
Published: 01 August 2022
2022, 1(2): 96-100
Total 30